Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ Silverii, G. A. Gabutti, G. Tafuri, S. Sarti, F. Pratesi, A. Clerico, A. Fornengo, R. Greco, C. Irace, C. Sordi, V. Sorice, G. P. Cavallo, M. Ponziani, M. C. Mannucci, E. Dicembrini, I.

Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies

  • Adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2024 ∙ Li, C. Thapa, D. Mi, Q. Gao, Y. Fu, X.

Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review

  • All age groups
  • Hepatitis B
  • Ethical issues
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Riley, A. G. Voehler, D. Mitrovich, R. Carias, C. Ollendorf, D. A. Nelson, K. L. Synnott, P. G. Eiden, A. L.

Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks

  • All age groups
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Zhang, J. Lian, Z. Xue, X. Li, J. Zhu, Y. Huang, N. Xie, W.

Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination

  • All age groups
  • Pregnant women
  • Human papillomavirus (HPV)
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Kaur, H. Chauhan, A. Mascarenhas, M.

Does SARS Cov-2 infection affect the IVF outcome - A systematic review and meta-analysis

  • All age groups
  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Valeriani, F. Protano, C. Pozzoli, A. Vitale, K. Liguori, F. Liguori, G. Galle, F.

Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis

  • All age groups
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Yeh, Y. T. Tsai, T. F.

Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Tuberculosis
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Skare, T. L. de Carvalho, J. F. de Medeiros, I. R. T. Shoenfeld, Y.

Ear abnormalities in chronic fatigue syndrome (CFS), fibromyalgia (FM), Coronavirus-19 infectious disease (COVID) and long-COVID syndrome (PCS), sick-building syndrome (SBS), post-orthostatic tachycardia syndrome (PoTS), and autoimmune/inflammatory syndrome induced by adjuvants (ASIA): A systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Burch, E. Khan, S. A. Stone, J. Asgharzadeh, A. Dawe, J. Ward, Z. Brooks-Pollock, E. Christensen, H.

Early mathematical models of COVID-19 vaccination in high-income countries: a systematic review

  • All age groups
  • COVID-19
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Chang, E. Li, H. Zheng, W. Zhou, L. Jia, Y. Gu, W. Cao, Y. Zhu, X. Xu, J. Liu, B. You, M. Liu, K. Wang, M. Huang, W.

Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...